Skip to main content
Top
Published in: BMC Surgery 1/2020

01-12-2020 | Gastric Cancer | Research article

Survival analysis in gastric cancer: a multi-center study among Iranian patients

Authors: Atefeh Talebi, Afsaneh Mohammadnejad, Abolfazl Akbari, Mohamad Amin Pourhoseingholi, Hassan Doosti, Bijan Moghimi-Dehkordi, Shahram Agah, Mansour Bahardoust

Published in: BMC Surgery | Issue 1/2020

Login to get access

Abstract

Background

Gastric cancer (GC) has been considered as the 5th most common type of cancer and the third leading cause of cancer-associated death worldwide. The aim of this historical cohort study was to evaluate the survival predictors for all patients with GC using the Cox proportional hazards, extended Cox, and gamma-frailty models.

Methods

This historical cohort study was performed according to documents of 1695 individuals having GC referred to three medical centers in Iran from 2001 to 2018. First, most significant prognostic risk factors on survival were selected, Cox proportional hazards, extended Cox, gamma-frailty models were applied to evaluate the effects of the risk factors, and then these models were compared with the Akaike information criterion.

Results

The age of patients, body mass index (BMI), tumor size, type of treatment and grade of the tumor increased the hazard rate (HR) of GC patients in both the Cox and frailty models (P < 0.05). Also, the size of the tumor and BMI were considered as time-varying variables in the extended Cox model. Moreover, the frailty model showed that there is at least an unknown factor, genetic or environmental factors, in the model that is not measured (P < 0.05).

Conclusions

Some prognostic factors, including age, tumor size, the grade of the tumor, type of treatment and BMI, were regarded as indispensable predictors in patients of GC. Frailty model revealed that there are unknown or latent factors, genetic and environmental factors, resulting in the biased estimates of the regression coefficients.
Literature
1.
go back to reference Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F. Global cancer Observatory: cancer today. Lyon: International agency for research on cancer. Cancer Today; 2018. Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F. Global cancer Observatory: cancer today. Lyon: International agency for research on cancer. Cancer Today; 2018.
2.
go back to reference Jenabi E, Saatchi M, Khazaei S, Mansori K, Ayubi E, Soheylizad M, Khazaei L, Nematollahi S, Beigi AM. National distribution of stomach cancer incidence in Iran: a population-based study. Adv Hum Biol. 2019;9(1):89.CrossRef Jenabi E, Saatchi M, Khazaei S, Mansori K, Ayubi E, Soheylizad M, Khazaei L, Nematollahi S, Beigi AM. National distribution of stomach cancer incidence in Iran: a population-based study. Adv Hum Biol. 2019;9(1):89.CrossRef
3.
go back to reference Zarea K, Beiranvand S, Ghanbari S, Tuvesson H. Incidence of gastrointestinal cancers in Iran: a systematic review. Jundishapur J Chronic Dis Care. 2017;6(1):e37224. Zarea K, Beiranvand S, Ghanbari S, Tuvesson H. Incidence of gastrointestinal cancers in Iran: a systematic review. Jundishapur J Chronic Dis Care. 2017;6(1):e37224.
4.
go back to reference Yaprak G, Tataroglu D, Dogan B, Pekyurek M. Prognostic factors for survival in patients with gastric cancer: single-Centre experience. Northern Clin Istanb. 2020;7(2):146. Yaprak G, Tataroglu D, Dogan B, Pekyurek M. Prognostic factors for survival in patients with gastric cancer: single-Centre experience. Northern Clin Istanb. 2020;7(2):146.
5.
go back to reference Yoshida N, Doyama H, Yano T, Horimatsu T, Uedo N, Yamamoto Y, Kakushima N, Kanzaki H, Hori S, Yao K: Early gastric cancer detection in high-risk patients: a multicentre randomised controlled trial on the effect of second-generation narrow band imaging. Gut. 2020;1–9. Yoshida N, Doyama H, Yano T, Horimatsu T, Uedo N, Yamamoto Y, Kakushima N, Kanzaki H, Hori S, Yao K: Early gastric cancer detection in high-risk patients: a multicentre randomised controlled trial on the effect of second-generation narrow band imaging. Gut. 2020;1–9.
6.
go back to reference Kleinbaum DG, Klein M. Survival analysis, vol. 3: Springer; 2010. Kleinbaum DG, Klein M. Survival analysis, vol. 3: Springer; 2010.
7.
go back to reference Klein JP, Van Houwelingen HC, Ibrahim JG, Scheike TH. Handbook of survival analysis. CRC Press; 2016. Klein JP, Van Houwelingen HC, Ibrahim JG, Scheike TH. Handbook of survival analysis. CRC Press; 2016.
8.
go back to reference Liu M, Li L, Yu W, Chen J, Xiong W, Chen S, Yu L. Marriage is a dependent risk factor for mortality of colon adenocarcinoma without a time-varying effect. Oncotarget. 2017;8(12):20056.CrossRef Liu M, Li L, Yu W, Chen J, Xiong W, Chen S, Yu L. Marriage is a dependent risk factor for mortality of colon adenocarcinoma without a time-varying effect. Oncotarget. 2017;8(12):20056.CrossRef
9.
go back to reference Moore DF. Applied survival analysis using R: Springer; 2016. Moore DF. Applied survival analysis using R: Springer; 2016.
10.
go back to reference Hanagal DD. Frailty Models in Public Health. In: Handbook of Statistics, vol. 37: Elsevier; 2017. p. 209–47. Hanagal DD. Frailty Models in Public Health. In: Handbook of Statistics, vol. 37: Elsevier; 2017. p. 209–47.
11.
go back to reference Amoori N, Mahdavi S, Enayatrad M. Epidemiology and trend of stomach cancer mortality in Iran. Int J Epidemiol Res. 2016;3(3):268–75. Amoori N, Mahdavi S, Enayatrad M. Epidemiology and trend of stomach cancer mortality in Iran. Int J Epidemiol Res. 2016;3(3):268–75.
12.
go back to reference Charati JY, Janbabaei G, Alipour N, Mohammadi S, Gholiabad SG, Fendereski A. Survival prediction of gastric cancer patients by artificial neural network model. Gastroenterol Hepatol Bed Bench. 2018;11(2):110. Charati JY, Janbabaei G, Alipour N, Mohammadi S, Gholiabad SG, Fendereski A. Survival prediction of gastric cancer patients by artificial neural network model. Gastroenterol Hepatol Bed Bench. 2018;11(2):110.
13.
go back to reference Faradmal J, Talebi A, Rezaianzadeh A, Mahjub H. Survival analysis of breast cancer patients using cox and frailty models. J Res Health Sci. 2012;12(2):127–30.PubMed Faradmal J, Talebi A, Rezaianzadeh A, Mahjub H. Survival analysis of breast cancer patients using cox and frailty models. J Res Health Sci. 2012;12(2):127–30.PubMed
14.
go back to reference Viúdez A, Carmona-Bayonas A, Gallego J, Lacalle A, Hernández R, Cano J, Macías I, Custodio A, de Castro EM, Sánchez A. Optimal duration of first-line chemotherapy for advanced gastric cancer: data from the AGAMENON registry. Clin Transl Oncol. 2019:1–17. Viúdez A, Carmona-Bayonas A, Gallego J, Lacalle A, Hernández R, Cano J, Macías I, Custodio A, de Castro EM, Sánchez A. Optimal duration of first-line chemotherapy for advanced gastric cancer: data from the AGAMENON registry. Clin Transl Oncol. 2019:1–17.
15.
go back to reference Lu J, Cao L-L, Zheng C-H, Li P, Xie J-W, Wang J-B, Lin J-X, Chen Q-Y, Lin M, Tu R-H. The preoperative frailty versus inflammation-based prognostic score: which is better as an objective predictor for gastric cancer patients 80 years and older? Ann Surg Oncol. 2017;24(3):754–62.CrossRef Lu J, Cao L-L, Zheng C-H, Li P, Xie J-W, Wang J-B, Lin J-X, Chen Q-Y, Lin M, Tu R-H. The preoperative frailty versus inflammation-based prognostic score: which is better as an objective predictor for gastric cancer patients 80 years and older? Ann Surg Oncol. 2017;24(3):754–62.CrossRef
16.
go back to reference Ghadimi M, Mahmoodi M, Mohammad K, Zeraati H, Rasouli M, Sheikhfathollahi M. Family history of the cancer on the survival of the patients with gastrointestinal cancer in northern Iran, using frailty models. BMC Gastroenterol. 2011;11(1):104.CrossRef Ghadimi M, Mahmoodi M, Mohammad K, Zeraati H, Rasouli M, Sheikhfathollahi M. Family history of the cancer on the survival of the patients with gastrointestinal cancer in northern Iran, using frailty models. BMC Gastroenterol. 2011;11(1):104.CrossRef
17.
go back to reference Pourhoseingholi MA, Hajizadeh E, Moghimi Dehkordi B, Safaee A, Abadi A, Zali MR. Comparing cox regression and parametric models for survival of patients with gastric carcinoma. Asian Pac J Cancer Prev. 2007;8(3):412.PubMed Pourhoseingholi MA, Hajizadeh E, Moghimi Dehkordi B, Safaee A, Abadi A, Zali MR. Comparing cox regression and parametric models for survival of patients with gastric carcinoma. Asian Pac J Cancer Prev. 2007;8(3):412.PubMed
18.
go back to reference Moghimi-Dehkordi B, Safaee A, Pourhoseingholi MA, Fatemi R, Tabeie Z, Zali MR. Statistical comparison of survival models for analysis of cancer data. Asian Pac J Cancer Prev. 2008;9(3):417–20.PubMed Moghimi-Dehkordi B, Safaee A, Pourhoseingholi MA, Fatemi R, Tabeie Z, Zali MR. Statistical comparison of survival models for analysis of cancer data. Asian Pac J Cancer Prev. 2008;9(3):417–20.PubMed
19.
go back to reference Perperoglou A, Keramopoullos A, van Houwelingen HC. Approaches in modelling long-term survival: an application to breast cancer. Stat Med. 2007;26(13):2666–85.CrossRef Perperoglou A, Keramopoullos A, van Houwelingen HC. Approaches in modelling long-term survival: an application to breast cancer. Stat Med. 2007;26(13):2666–85.CrossRef
20.
go back to reference Pelagia I. Variable Selection of Fixed Effects and Frailties for Cox Proportional Hazard Frailty Models and Competing Risks Frailty Models: The University of Manchester (United Kingdom); 2016. Pelagia I. Variable Selection of Fixed Effects and Frailties for Cox Proportional Hazard Frailty Models and Competing Risks Frailty Models: The University of Manchester (United Kingdom); 2016.
21.
go back to reference Baghestani AR, Pourhoseingholi MA, Ashtari S, Najafimehr H, Busani L, Zali MR. Trend of gastric Cancer after Bayesian correction of misclassification error in neighboring provinces of Iran. Galen Med J. 2019;8:1223.CrossRef Baghestani AR, Pourhoseingholi MA, Ashtari S, Najafimehr H, Busani L, Zali MR. Trend of gastric Cancer after Bayesian correction of misclassification error in neighboring provinces of Iran. Galen Med J. 2019;8:1223.CrossRef
22.
go back to reference Ghaffari HR, Yunesian M, Nabizadeh R, Nasseri S, Sadjadi A, Pourfarzi F, Poustchi H, Eshraghian A. Environmental etiology of gastric cancer in Iran: a systematic review focusing on drinking water, soil, food, radiation, and geographical conditions. Environ Sci Pollut Res. 2019;26(11):10487–95.CrossRef Ghaffari HR, Yunesian M, Nabizadeh R, Nasseri S, Sadjadi A, Pourfarzi F, Poustchi H, Eshraghian A. Environmental etiology of gastric cancer in Iran: a systematic review focusing on drinking water, soil, food, radiation, and geographical conditions. Environ Sci Pollut Res. 2019;26(11):10487–95.CrossRef
23.
go back to reference Rastaghi S, Jafari-Koshki T, Mahaki B, Bashiri Y, Mehrabani K, Soleimani A. Trends and risk factors of gastric cancer in Iran (2005–2010). Int J Prev Med. 2019;10. Rastaghi S, Jafari-Koshki T, Mahaki B, Bashiri Y, Mehrabani K, Soleimani A. Trends and risk factors of gastric cancer in Iran (2005–2010). Int J Prev Med. 2019;10.
24.
go back to reference Katai H, Ishikawa T, Akazawa K, Isobe Y, Miyashiro I, Oda I, Tsujitani S, Ono H, Tanabe S, Fukagawa T. Five-year survival analysis of surgically resected gastric cancer cases in Japan: a retrospective analysis of more than 100,000 patients from the nationwide registry of the Japanese gastric Cancer association (2001–2007). Gastric Cancer. 2018;21(1):144–54.CrossRef Katai H, Ishikawa T, Akazawa K, Isobe Y, Miyashiro I, Oda I, Tsujitani S, Ono H, Tanabe S, Fukagawa T. Five-year survival analysis of surgically resected gastric cancer cases in Japan: a retrospective analysis of more than 100,000 patients from the nationwide registry of the Japanese gastric Cancer association (2001–2007). Gastric Cancer. 2018;21(1):144–54.CrossRef
25.
go back to reference Morgan R, Cassidy M, DeGeus SW, Tseng J, McAneny D, Sachs T. Presentation and survival of gastric Cancer patients at an urban academic safety-net hospital. J Gastrointest Surg. 2019;23(2):239–46.CrossRef Morgan R, Cassidy M, DeGeus SW, Tseng J, McAneny D, Sachs T. Presentation and survival of gastric Cancer patients at an urban academic safety-net hospital. J Gastrointest Surg. 2019;23(2):239–46.CrossRef
26.
go back to reference van Putten M, Nelen S, Lemmens V, Stoot J, Hartgrink H, Gisbertz SS, Spillenaar Bilgen EJ, Heisterkamp J, Verhoeven R, Nieuwenhuijzen G. Overall survival before and after centralization of gastric cancer surgery in the Netherlands. Br J Surg. 2018;105(13):1807–15.CrossRef van Putten M, Nelen S, Lemmens V, Stoot J, Hartgrink H, Gisbertz SS, Spillenaar Bilgen EJ, Heisterkamp J, Verhoeven R, Nieuwenhuijzen G. Overall survival before and after centralization of gastric cancer surgery in the Netherlands. Br J Surg. 2018;105(13):1807–15.CrossRef
27.
go back to reference Henrik Nienhueser RK, Sisic L, Blank S, Strowitzk MJ, Bruckner T, Jager D, Weichert W, Alexis Ulrich MB, Ott K, Schmidt T. Surgery of Gastric Cancer and Esophageal Cancer: Does Age Matter? J Surg Oncol. 2015;112:387–95.CrossRef Henrik Nienhueser RK, Sisic L, Blank S, Strowitzk MJ, Bruckner T, Jager D, Weichert W, Alexis Ulrich MB, Ott K, Schmidt T. Surgery of Gastric Cancer and Esophageal Cancer: Does Age Matter? J Surg Oncol. 2015;112:387–95.CrossRef
28.
go back to reference Naseri P, Baghestani AR, Momenyan N, Akbari ME. Application of a mixture cure fraction model based on the generalized modified weibull distribution for analyzing survival of patients with breast cancer. Int J Cancer Manage. 2018;11(5). Naseri P, Baghestani AR, Momenyan N, Akbari ME. Application of a mixture cure fraction model based on the generalized modified weibull distribution for analyzing survival of patients with breast cancer. Int J Cancer Manage. 2018;11(5).
29.
go back to reference Liu BZ, Tao L, Chen YZ, Li XZ, Dong YL, Ma YJ, Li SG, Li F, Zhang WJ. Preoperative body mass index, blood albumin and triglycerides predict survival for patients with gastric cancer. PLoS One. 2016;11(6). Liu BZ, Tao L, Chen YZ, Li XZ, Dong YL, Ma YJ, Li SG, Li F, Zhang WJ. Preoperative body mass index, blood albumin and triglycerides predict survival for patients with gastric cancer. PLoS One. 2016;11(6).
30.
go back to reference Dongyun Yang AH, Lenz C, Togawa K, Lenz F, Lurje G, Pohl A, Winder T, Ning Y, Groshen S, Lenz H-J. Survival of metastatic gastric cancer: significance of age, sex and race/ethnicity. J Gastrointest Oncol. 2011;2(2):77–84.PubMedPubMedCentral Dongyun Yang AH, Lenz C, Togawa K, Lenz F, Lurje G, Pohl A, Winder T, Ning Y, Groshen S, Lenz H-J. Survival of metastatic gastric cancer: significance of age, sex and race/ethnicity. J Gastrointest Oncol. 2011;2(2):77–84.PubMedPubMedCentral
31.
go back to reference Zhang X-F, Huang C-M, Lu H-S, Wu X-Y, Wang C, Guang G-X, Zhang J-Z, Zheng C-H. Surgical treatment and prognosis of gastric cancer in 2613 patients. World J Gastroenterol: WJG. 2004;10(23):3405.CrossRef Zhang X-F, Huang C-M, Lu H-S, Wu X-Y, Wang C, Guang G-X, Zhang J-Z, Zheng C-H. Surgical treatment and prognosis of gastric cancer in 2613 patients. World J Gastroenterol: WJG. 2004;10(23):3405.CrossRef
32.
go back to reference Moghimbeigi A, Tapak L, Roshanaei G, Mahjub H. Survival analysis of gastric cancer patients with incomplete data. J Gastric Cancer. 2014;14(4):259–65.CrossRef Moghimbeigi A, Tapak L, Roshanaei G, Mahjub H. Survival analysis of gastric cancer patients with incomplete data. J Gastric Cancer. 2014;14(4):259–65.CrossRef
33.
go back to reference Orditura M, Galizia G, Sforza V, Gambardella V, Fabozzi A, Laterza MM, Andreozzi F, Ventriglia J, Savastano B, Mabilia A. Treatment of gastric cancer. World J Gastroenterol: WJG. 2014;20(7):1635.CrossRef Orditura M, Galizia G, Sforza V, Gambardella V, Fabozzi A, Laterza MM, Andreozzi F, Ventriglia J, Savastano B, Mabilia A. Treatment of gastric cancer. World J Gastroenterol: WJG. 2014;20(7):1635.CrossRef
34.
go back to reference Sarveazad A, Agah S, Babahajian A, Amini N, Bahardoust M. Predictors of 5 year survival rate in hepatocellular carcinoma patients. J Res Med Sci. 2019;24. Sarveazad A, Agah S, Babahajian A, Amini N, Bahardoust M. Predictors of 5 year survival rate in hepatocellular carcinoma patients. J Res Med Sci. 2019;24.
35.
go back to reference Nikaeen R, Khalilian A, Bahrampour A. Determining the effective factors on gastric cancer using frailty model in South-East and North of Iran. 2017;5(3):35-48. Nikaeen R, Khalilian A, Bahrampour A. Determining the effective factors on gastric cancer using frailty model in South-East and North of Iran. 2017;5(3):35-48.
Metadata
Title
Survival analysis in gastric cancer: a multi-center study among Iranian patients
Authors
Atefeh Talebi
Afsaneh Mohammadnejad
Abolfazl Akbari
Mohamad Amin Pourhoseingholi
Hassan Doosti
Bijan Moghimi-Dehkordi
Shahram Agah
Mansour Bahardoust
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Surgery / Issue 1/2020
Electronic ISSN: 1471-2482
DOI
https://doi.org/10.1186/s12893-020-00816-6

Other articles of this Issue 1/2020

BMC Surgery 1/2020 Go to the issue